About The Company : Wide range of ophthalmic products, nasal spray, drops along with a variety of contract manufacturing services. Read More

Wide range of ophthalmic products, nasal spray, drops along with a variety of contract manufacturing services.

Pharma Services & Categories :  

Eye Drops Solutions

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Formulation Development >> Ophthalmic

Sterile Spray Solutions

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Formulation Development >> Overview

Solid Dosage Forms- Tablet

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Formulation Development >> Tablet

Solid Dosage Forms- Capsule

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Formulation Development >> Capsule

Technology Transfer

Together with JGL Production, JGL R&D provides technology transfer for all co-development or/and co-manufacture formulations and manufacturing processes. The validation of technology transfer guarantees success in each successive batch of a new product.

Formulation Development >> Tech Transfer

ICH Compliant Stability Control

A wide range of ICH conditions of walk in/reach in chambers, refrigerated and freezer storages which are fully controlled and monitored. 24 hour alarm system is on site, along with a dedicated team trained to respond to any deviations from the set storage conditions.

Stability Studies >> Overview

Microbiological Limits Testing

JGL's analytical laboratory is GMP certified and offers microbiology testing which includes Microbiological Limits testing; Presence/Absence of Pathogens; Sterility testing; LAL testing; Identification of microorganisms.

Analytical Testing Services >> Microbiology

Sterility Testing

JGL's analytical laboratory is GMP certified and offers microbiology testing which includes Microbiological Limits testing; Presence/Absence of Pathogens; Sterility testing; LAL testing; Identification of microorganisms.

Analytical Testing Services >> Microbiology

Syrup Formulations

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Syrup >> Oral

Dermatological Solutions

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Formulation Development >> Cream / Gel / Lotion / Ointment

Semi Solid Topical Preparations

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Formulation Development >> Cream / Gel / Lotion / Ointment

Powders

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

Formulation Development >> Powder / Blend

Production of Tablets

JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.

Tablet >> Overview

Production of Capsules

JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.

Capsule >> Overview

Production of Oral Powders

JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.

Powder >> Oral

Manufacturing Capabilities for Ointments

JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.

Cream / Lotion / Ointment >> Overview

Manufacturing Capabilities for Creams

JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.

Cream / Lotion / Ointment >> Overview

Manufacturing Capabilities for Gels

JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.

Gel >> Overview

Manufacturing Capabilities for Lotions

JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.

Cream / Lotion / Ointment >> Overview

Production of Sterile Nasal Drops

Pharma Valley, the new facility that opened in July 2015, JGL is ranked among the leading manufacturers of sterile pharmaceutical forms (drops, sprays and BoV) in the European Union. The total value of the Svilno investment, located in Rijeka's hinterland, amounts to EUR 48 million.

Solution >> Nasal, Nasal